{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:17:18Z","timestamp":1790788638732,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000301","name":"Breast Cancer Campaign","doi-asserted-by":"publisher","award":["2013NovSP218"],"award-info":[{"award-number":["2013NovSP218"]}],"id":[{"id":"10.13039\/501100000301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Imperial and Leicester ECMCs"},{"name":"Cancer Research UK Leicester Centre to the University of Leicester"},{"name":"Cancer Research UK Clinical and Translational Research Committee programme","award":["C14315\/A13462X"],"award-info":[{"award-number":["C14315\/A13462X"]}]},{"DOI":"10.13039\/501100000738","name":"University of Leicester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Breast cancer tissues are heterogeneous and show diverse somatic mutations and somatic copy number alterations (CNAs). We used a novel targeted next generation sequencing (NGS) panel to examine cell-free DNA (cfDNA) to detect somatic mutations and gene amplification in women with metastatic breast cancer (MBC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>cfDNA from pretreated patients (n = 42) and 9 healthy controls were compared with matched lymphocyte DNA by NGS, using a custom 158 amplicon panel covering hot-spot mutations and CNAs in 16 genes, with further validation of results by droplet digital PCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>No mutations were identified in cfDNA of healthy controls, whereas exactly half the patients with metastatic breast cancer had at least one mutation or amplification in cfDNA (mean 2, range 1\u20136) across a total of 13 genes. Longitudinal follow up showed dynamic changes to mutations and gene amplification in cfDNA indicating clonal and subclonal response to treatment that was more dynamic than cancer antigen 15-3 (CA15-3). Interestingly, at the time of blood sampling disease progression was occurring in 7 patients with erb-b2 receptor tyrosine kinase 2 (ERBB2) gene amplification in their cfDNA and 3 of these patients were human epidermal growth factor receptor 2 (HER2) negative at diagnosis, suggesting clonal evolution to a more aggressive phenotype. Lastly, 6 patients harbored estrogen receptor 1 (ESR1) mutations in cfDNA, suggesting resistance to endocrine therapy. Overall 9 of 42 patients (21%) had alterations in cfDNA that could herald a change in treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Targeted NGS of cfDNA has potential for monitoring response to targeted therapies through both mutations and gene amplification, for analysis of dynamic tumor heterogeneity and stratification to targeted therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2016.261834","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T22:26:42Z","timestamp":1481322402000},"page":"532-541","source":"Crossref","is-referenced-by-count":84,"title":["Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer"],"prefix":"10.1093","volume":"63","author":[{"given":"Karen","family":"Page","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Guttery","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fernandez-Garcia","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hills","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Division of Cancer, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K","family":"Hastings","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Goddard","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedia","family":"Shahin","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Woodley-Barker","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Imperial College London, Charing Cross Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M","family":"Rosales","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Division of Cancer, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Charles","family":"Coombes","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Division of Cancer, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Stebbing","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, Division of Cancer, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A","family":"Shaw","sequence":"first","affiliation":[{"name":"Department of Cancer Studies and Cancer Research UK Leicester Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"2020022606065113000_B1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2020022606065113000_B2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature08768","article-title":"Signatures of mutation and selection in the cancer genome","volume":"463","author":"Bignell","year":"2010","journal-title":"Nature"},{"key":"2020022606065113000_B3","doi-asserted-by":"crossref","first-page":"16224","DOI":"10.1073\/pnas.0808041105","article-title":"Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers","volume":"105","author":"Leary","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606065113000_B4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"2020022606065113000_B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"2020022606065113000_B6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"2020022606065113000_B7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg3463","article-title":"Disease-targeted sequencing: a cornerstone in the clinic","volume":"14","author":"Rehm","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2020022606065113000_B8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1373\/clinchem.2015.238717","article-title":"Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer","volume":"61","author":"Guttery","year":"2015","journal-title":"Clin Chem"},{"key":"2020022606065113000_B9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1101\/gr.123497.111","article-title":"Genomic analysis of circulating cell-free DNA infers breast cancer dormancy","volume":"22","author":"Shaw","year":"2012","journal-title":"Genome Res"},{"key":"2020022606065113000_B10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1373\/clinchem.2014.234286","article-title":"Rapid identification of plasma DNA samples with increased ctDNA levels by a modified FAST-SeqS approach","volume":"61","author":"Belic","year":"2015","journal-title":"Clin Chem"},{"key":"2020022606065113000_B11","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-12-3768","article-title":"Noninvasive detection of HER2 amplification with plasma DNA digital PCR","volume":"19","author":"Gevensleben","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2020022606065113000_B12","doi-asserted-by":"crossref","first-page":"e77963","DOI":"10.1371\/journal.pone.0077963","article-title":"Influence of plasma processing on recovery and analysis of circulating nucleic acids","volume":"8","author":"Page","year":"2013","journal-title":"PLoS One"},{"key":"2020022606065113000_B13","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/bcr2251","article-title":"Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms","volume":"11","author":"Hancox","year":"2009","journal-title":"Breast Cancer Res"},{"key":"2020022606065113000_B14","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2020022606065113000_B15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"2020022606065113000_B16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"2020022606065113000_B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"Mutationtaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods"},{"key":"2020022606065113000_B18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2020022606065113000_B19","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/bioinformatics\/btu436","article-title":"Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data","volume":"30","author":"Boeva","year":"2014","journal-title":"Bioinformatics"},{"key":"2020022606065113000_B20","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","article-title":"A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data","volume":"27","author":"Li","year":"2011","journal-title":"Bioinformatics"},{"key":"2020022606065113000_B21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"Bedtools: A flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"2020022606065113000_B22","unstructured":"Primer3. http:\/\/primer3.ut.ee\/ (Accessed January 2014)."},{"key":"2020022606065113000_B23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"key":"2020022606065113000_B24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-015-0292-6","article-title":"Identification of rare germline copy number variations over-represented in five human cancer types","volume":"14","author":"Park","year":"2015","journal-title":"Mol Cancer"},{"key":"2020022606065113000_B25","doi-asserted-by":"crossref","first-page":"313ra182","DOI":"10.1126\/scitranslmed.aac7551","article-title":"Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer","volume":"7","author":"Schiavon","year":"2015","journal-title":"Sci Transl Med"},{"key":"2020022606065113000_B26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tranon.2015.08.004","article-title":"Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology","volume":"8","author":"Kirkizlar","year":"2015","journal-title":"Transl Oncol"},{"key":"2020022606065113000_B27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"2020022606065113000_B28","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1073\/pnas.1105422108","article-title":"Detection and quantification of rare mutations with massively parallel sequencing","volume":"108","author":"Kinde","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606065113000_B29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nmeth898","article-title":"Beaming: Single-molecule PCR on microparticles in water-in-oil emulsions","volume":"3","author":"Diehl","year":"2006","journal-title":"Nat Methods"},{"key":"2020022606065113000_B30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/2159-8290.CD-12-0196","article-title":"From differences in means between cases and controls to risk stratification: a business plan for biomarker development","volume":"3","author":"Wentzensen","year":"2013","journal-title":"Cancer Discov"},{"key":"2020022606065113000_B31","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/bjc.2011.89","article-title":"Detection of HER2 amplification in circulating free DNA in patients with breast cancer","volume":"104","author":"Page","year":"2011","journal-title":"Br J Cancer"},{"key":"2020022606065113000_B32","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/1078-0432.CCR-15-0584","article-title":"Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration","volume":"21","author":"Frenel","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2020022606065113000_B33","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"2020022606065113000_B34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molonc.2012.01.001","article-title":"Structural and genic characterization of stable genomic regions in breast cancer: relevance to chemotherapy","volume":"6","author":"Park","year":"2012","journal-title":"Mol Oncol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/2\/532\/32645605\/clinchem0532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/63\/2\/532\/32645605\/clinchem0532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T06:18:01Z","timestamp":1582697881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/63\/2\/532\/5612838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,1]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2016.261834","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,1]]},"published":{"date-parts":[[2017,2,1]]}}}